Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging 18F-FDG PET Imaging Biomarkers in Patients with Esophageal Cancer-Reference-Cited by-同舟云学术

Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging 18F-FDG PET Imaging Biomarkers in Patients with Esophageal Cancer

Published:2018-06 Issue:3 Volume:287 Page:983-992
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Beukinga Roelof J.^ORCID,Hulshoff Jan Binne,Mul Véronique E. M.,Noordzij Walter,Kats-Ugurlu Gursah,Slart Riemer H. J. A.,Plukker John T. M.

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

https://pubs.rsna.org/doi/pdf/10.1148/radiol.2018172229

Reference28 articles.

1. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

2. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

3. Recurrence pattern in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer17

4. Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response and those with partial or no response?

5. Different Recurrence Pattern After Neoadjuvant Chemoradiotherapy Compared to Surgery Alone in Esophageal Cancer Patients

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline 18F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma with extranodal involvement;Clinical and Translational Oncology;2024-07-31

2. Radiomics based on 18F-FDG PET/CT for prediction of pathological complete response to neoadjuvant therapy in non-small cell lung cancer;Frontiers in Oncology;2024-07-26

3. Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: Interim analysis of the prospective ESCAPE trial;Radiotherapy and Oncology;2024-05

4. Remarkable response as a new indicator for endoscopic evaluation of local efficacy of non-surgical treatments for esophageal cancer;Esophagus;2024-02-14

5. Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective;Pharmacology & Therapeutics;2024-02